Huuskonen P, Myllynen P, Storvik M, Pasanen M. The effects of aflatoxin B1 on transporters and steroid metabolizing enzymes in JEG-3 cells. Toxicol Lett. 2013;218:200-6 pubmed publisher

Liu Y, Han T, Giuliano A, Hansen N, Cabot M. Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem. 2000;275:7138-43 pubmed

Giddings E, Champagne D, Wu M, Laffin J, Thornton T, Valença Pereira F, et al. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nat Commun. 2021;12:2804 pubmed publisher

Song Y, Park J, Oh Y, Hyung S, Jeong Y, Kim M, et al. Suppression of Canine ATP Binding Cassette ABCB1 in Madin-Darby Canine Kidney Type II Cells Unmasks Human ABCG2-Mediated Efflux of Olaparib. J Pharmacol Exp Ther. 2019;368:79-87 pubmed publisher

Afrouzian M, Al Lahham R, Patrikeeva S, Xu M, Fokina V, Fischer W, et al. Role of the efflux transporters BCRP and MRP1 in human placental bio-disposition of pravastatin. Biochem Pharmacol. 2018;156:467-478 pubmed publisher

Kang S, Haydar G, Taniane C, Farrell G, Arias I, Lippincott Schwartz J, et al. AMPK Activation Prevents and Reverses Drug-Induced Mitochondrial and Hepatocyte Injury by Promoting Mitochondrial Fusion and Function. PLoS ONE. 2016;11:e0165638 pubmed publisher

Beck W, Grogan T, Willman C, Cordon Cardo C, Parham D, Kuttesch J, et al. Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res. 1996;56:3010-20 pubmed

Lee J, Hughes C, Fine R, Page R. P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Cancer. 1996;77:1892-8 pubmed

Rao V, Anthony D, Piwnica Worms D. MDR1 gene-specific monoclonal antibody C494 cross-reacts with pyruvate carboxylase. Cancer Res. 1994;54:1536-41 pubmed